Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.58 |
| ▸ | MEN1 | O00255 | 5/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 3/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL27563712 | 0.92 | MEN1 (0.63) | MAPTMEN1KMT2ASMN1; SMN2POLB | |
| Isophthalic Acid SCHEMBL27904099 | 0.87 | MEN1 (0.57) | MAPTMEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL6716900 | 0.85 | MAPT (0.62) | MAPTMEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL7865726 | 0.84 | MAPT (0.60) | MAPTMEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL27699157 | 0.82 | MAPT (0.63) | MAPTMEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL651726 | 0.82 | MAPT (0.64) | MAPTMEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL356986 | 0.82 | MAPT (0.68) | MAPTMEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL30933151 | 0.82 | MAPT (0.68) | MAPTMEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL3068048 | 0.79 | HTR3E (0.61) | MAPTMEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL8332645 | 0.78 | TRPV1 (0.48) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1032556-A4 | PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE | CAMBRIDGE NEUROSCIENCE INC (US) | 2005-02-02 | — | — | EP | claimed |
| EP-1032556-A1 | PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE | CAMBRIDGE NEUROSCIENCE, INC. (US) | 2000-09-06 | — | — | EP | claimed |
| WO-1999020599-A1 | PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1999-04-29 | — | — | WO | claimed |
| EP-2766326-A1 | METHOD FOR THE SYNTHESIS OF 18F-LABELLED BIOMOLECULES | GE Healthcare UK Limited (GB) | 2014-08-20 | — | — | EP | disclosed |
| EP-2766325-A1 | METHOD FOR THE SYNTHESIS OF 18F-LABELLED BIOMOLECULES | GE Healthcare UK Limited (GB) | 2014-08-20 | — | — | EP | disclosed |
| WO-2013053940-A1 | METHOD FOR THE SYNTHESIS OF 18F-LABELLED BIOMOLECULES | GE HEALTHCARE LIMITED (GB) | 2013-04-18 | — | — | WO | disclosed |
| WO-2013053941-A1 | METHOD FOR THE SYNTHESIS OF 18F-LABELLED BIOMOLECULES | GE HEALTHCARE LIMITED (GB) | 2013-04-18 | — | — | WO | disclosed |
| WO-2004039371-A2 | COMPOSITIONS OF CYCLOOXYGENASE-2 SELECTIVE INHIBITORS AND NMDA RECEPTOR ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF NEUROPATHIC PAIN | PHARMACIA CORPORATION (US) | 2004-05-13 | — | — | WO | disclosed |